title: Prenatal management with digoxin and sotalol combination for fetal supraventricular tachycardia: case report and review of literature.
abstract: Sustained fetal supraventricular tachycardia (SVT) with a heart rate of approximately 210 bpm may lead to increased atrial and venous pressures and congestive heart failure. There is no clear consensus regarding the best drug-treatment regimens for fetal SVT. However, considerable nonrandomized experience in the transmaternal treatment of fetal SVT is available with a number of antiarrhythmic agents. We report a case of fetal supraventricular tachyarrhythmia with hydrops detected at 32 weeks that was managed with combination of oral digoxin and sotalol and review management guidelines available in the literature.
authors.affiliation: Department of Obstetrics and Gynecology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. dr_vanita_suri@yahoo.co.in
authors.forename: Vanita
authors.initials: V
authors.lastname: Suri
authors.forename: Anish
authors.initials: A
authors.lastname: Keepanaseril
authors.forename: Neelam
authors.initials: N
authors.lastname: Aggarwal
authors.forename: Rajesh
authors.initials: R
authors.lastname: Vijayvergiya
mesh_terms: D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D004077:Digoxin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015160:Hydrops Fetalis / Q000188:drug therapy; D007231:Infant, Newborn; D011247:Pregnancy; D011295:Prenatal Care; D013015:Sotalol / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*; D013617:Tachycardia, Supraventricular / Q000188:drug therapy*
chemical_list: D000889:Anti-Arrhythmia Agents; D013565:Sympatholytics; D004077:Digoxin; D013015:Sotalol